pillbase.ru

Aquipta

Active substance: atogepant

atogepant

Centralised EU authorisationActive

Marketing holder: AbbVie Deutschland GmbH & Co. KG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • КЬЮЛИПТА
    таблетки, 10 мг (original in Russian, GRLS)
    ЛП-№(006822)-(РГ-RU)
    Общество с ограниченной ответственностью "ЭббВи"
US 3
  • Qulipta
    TABLET · ATOGEPANT 30 mg/1
    0074-7096
    AbbVie Inc.
  • Qulipta
    TABLET · ATOGEPANT 60 mg/1
    0074-7094
    AbbVie Inc.
  • Qulipta
    TABLET · ATOGEPANT 10 mg/1
    0074-7095
    AbbVie Inc.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-80db-7775-ae97-66e71c69fc97;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208f-8409-778d-b16e-b64a5738b20d,01a12093-3e7d-7b60-8b11-24c4626dbdd4,01a1209c-cf6a-7290-aadc-43fff9f71190;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005871
Registration status
Active
ATC code
N02CD07
Sources
  • product · EMA · EMEA/H/C/005871 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005871 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005871 · Verified 2026-10-09